824 filings
Page 7 of 42
UPLOAD
a4v7 gs6iyp5e
22 Jan 21
Letter from SEC
12:00am
8-K
g0igxzh2k2n 3g00yz4u
22 Dec 20
Soligenix Announces Topline Results from its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients
9:15am
8-K
3dlae6k1twlwr
16 Dec 20
Soligenix Announces $20 Million Strategic Convertible Debt Financing Agreement with Pontifax Medison Debt Financing
4:31pm
8-K/A
79xd xcgzir
3 Dec 20
Amendments to Articles of Incorporation or Bylaws
4:35pm
DEFA14A
zgcvi02y3nixu
25 Nov 20
Additional proxy soliciting materials
7:31am
8-K
eh8oryj
25 Nov 20
Submission of Matters to a Vote of Security Holders
7:30am
8-K
dbx8mm
18 Sep 20
Amendments to Articles of Incorporation or Bylaws
4:31pm
8-K
8geo2x99it3rsz7hw4
10 Sep 20
Advantages of the CiVax™ Program for Development of a Broadly Distributed Heat Stable COVID-19 Vaccine
7:32am
EFFECT
hpn556ptku1hk4qs92u
31 Aug 20
Notice of effectiveness
12:15am
424B5
fhq3q 5c25n3
28 Aug 20
Prospectus supplement for primary offering
4:48pm
8-K
lsyauthlt4xc
28 Aug 20
Entry into a Material Definitive Agreement
4:37pm
CORRESP
qhmswektdzhtu1o
26 Aug 20
Correspondence with SEC
12:00am
DEFA14A
v2r2p8l8oaxfkn4nzi
13 Aug 20
Additional proxy soliciting materials
4:30pm
DEFA14A
nfh4bj0wv0ir9b7dug
7 Aug 20
Additional proxy soliciting materials
4:37pm